Brief: Heat Biologics Announces Planned Acquisition Of Elusys Therapeutics
21/12/2021 12:37
Dec 21 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS ANNOUNCES PLANNED ACQUISITION OF ELUSYS
THERAPEUTICS
* HEAT BIOLOGICS INC - UNDER TERMS OF MERGER AGREEMENT WITH
ELUSYS, HEAT WILL ACQUIRE ALL OUTSTANDING SHARES OF ELUSYS
* HEAT BIOLOGICS INC - FOLLOWING CLOSING OF ACQUISITION,
ELUSYS
WILL CONTINUE TO OPERATE AS WHOLLY OWNED SUBSIDIARY OF HEAT
Source text for Eikon: ID:nGNX1MMN2m
Further company coverage: HTBX.O
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company